Skip to main content
TipRanks
Go Ultimate75% OFF

Elevance Health (1ANTM) Stock Forecast & Price Target

3 Followers
See the Price Targets and Ratings of:

1ANTM Analyst Ratings

Moderate Buy
14Ratings
9Buy5Hold0Sell
Based on 14 analysts giving stock ratings to Elevance Health in the past 3 months

1ANTM Stock 12 Month Forecast

€427.56▲(11.78% Upside)
Based on 14 Wall Street analysts offering 12 month price targets for Elevance Health in the last 3 months. The average price target is EUR 427.56 with a high forecast of EUR 466.01 and a low forecast of EUR 361.76. The average price target represents a 11.78% change from the last price of EUR 382.50.
Highest Price Target€466.01Average Price Target€427.56Lowest Price Target€361.76

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for IT:1ANTM
Price TargetArticle
Bernstein€434.83→€463.34buy21.13%UpsideReiterated11/04/26
Wells Fargo€421.46→€438.39buy14.61%UpsideAssigned10/27/26
Mizuho Securities€418.79→€436.61buy14.15%UpsideReiterated10/23/26
TD Cowen€414.33→€441.06buy15.31%UpsideReiterated10/23/26
Bank of America Securities€445.52buy16.48%UpsideAssigned10/22/26
Barclays€417.90→€420.57buy9.95%UpsideReiterated10/22/26
Robert W. Baird€350.18→€361.76hold-5.42%DownsideReiterated10/22/26
Morgan Stanley€359.98→€400.08hold4.60%UpsideReiterated10/22/26
UBS€409.88→€466.01buy21.83%UpsideAssigned10/22/26
Truist Financial€423.24→€445.52buy16.48%UpsideReiterated10/22/26
Goldman Sachs€351.96→€401.86hold5.06%UpsideReiterated10/22/26
Guggenheim€409.88→€432.15buy12.98%UpsideReiterated10/21/26
RBC Capital€377.80→€405.42hold5.99%UpsideReiterated10/21/26
Argus Research―hold―Reiterated08/20/26
Leerink Partners€324.34→€351.96hold-7.98%DownsideReiterated07/17/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
MDWDMediwound
OVIDOvid Therapeutics
IMUXImmunic
QUITAchieve Life Sciences
COGTCogent Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Elevance Health

3 Months
Success Rate13/19 ratings generated profit
68%
Average Return
+0.98%

Copying Andrew Mok CFA's trades and holding each position for 3 Months would result in 68.42% of your transactions generating a profit, with an average return of +0.98% per trade.

1 Year
George Hill
George HillDeutsche Bank
Success Rate14/18 ratings generated profit
78%
Average Return
+15.86%

Copying George Hill's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +15.86% per trade.

2 Years
Success Rate27/30 ratings generated profit
90%
Average Return
+35.53%

Copying A.J. Rice's trades and holding each position for 2 Years would result in 90.00% of your transactions generating a profit, with an average return of +35.53% per trade.

1ANTM Analyst Recommendation Trends

010203040Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for 1ANTM
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00000
Buy2721202019
Hold99865
Sell00000
Strong Sell00000
total3630282624

In the current month, 1ANTM has received 19 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. 1ANTM average Analyst price target in the past 3 months is 427.56.

1ANTM Financial Forecast

€0€3€6€9€12Q1 2026Q3 2026Q4 2026
High€2.89
Consensus€1.87
Low€1.47

1ANTM Earnings Forecast

Next quarter’s earnings estimate for 1ANTM is EUR 1.87 with a range of EUR 1.47 to EUR 2.89. The previous quarter’s EPS was EUR 6.28. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€42.3B€43.4B€44.5B€45.6B€46.7BQ1 2026Q3 2026Q4 2026
High€46.7B
Consensus€44.4B
Low€42.3B

1ANTM Sales Forecast

Next quarter’s sales forecast for 1ANTM is EUR 44.39B with a range of EUR 42.27B to EUR 46.74B. The previous quarter’s sales results were EUR 46.23B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

1ANTM Stock Forecast FAQ

What is IT:1ANTM’s average 12-month price target, according to analysts?
Based on analyst ratings, Elevance Health’s 12-month average price target is €427.56.
What is IT:1ANTM’s upside potential, based on the analysts’ average price target?
Elevance Health has 11.78% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Elevance Health a Buy, Sell or Hold?
Elevance Health has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 5 hold ratings and 0 sell ratings.
What is Elevance Health’s share price target?
The average share price target for Elevance Health is €427.56. This is based on 14 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €466.01, and the lowest forecast is €361.76. The average share price target represents a 11.78% increase from the current price of €382.5.
What do analysts say about Elevance Health?
Elevance Health’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Street analysts.
How can I buy shares of Elevance Health?
To buy shares of IT:1ANTM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.